Course: Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel
CME Credits: 1.00
Released: 2022-03-17
Vaccination has limited SARS-CoV-2 spread and prevented major illness and death during the COVID-19 pandemic. However, certain adverse events, such as an increased incidence of myocarditis, particularly in young men, have been associated with vaccination with the BNT162b2 mRNA vaccine (Pfizer-BioNTech).,
Educational Objective
To identify the key insights or developments described in this article
View Full Course